| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
01.05.2025 13:29:21
|
Biogen Q1 Results Top Estimates; Lowers FY25 Adj. EPS Outlook
(RTTNews) - Biotechnology company Biogen, Inc. (BIIB) reported Thursday that net income attributable to the company for the first quarter grew to $240.5 million or $1.64 per share from $393.4 million or $2.70 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $3.02 per share, compared to $3.67 per share in the year-ago quarter.
On average, 24 analysts polled expected the company to report earnings of $2.96 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenue for the quarter grew 6 percent to $2.43 billion from $2.29 billion in the same quarter last year. Revenues were up 8 percent in constant currency. Analysts expected revenues of $2.23 billion for the quarter.
Looking ahead to fiscal 2025, the company now projects adjusted earnings in a range of $14.50 to $15.50 per share on a total revenue decline in the mid-single digits at constant currency to reflect the $165 million upfront transaction payment to Stoke and more favorable foreign exchange.
Previously, the company expected adjusted earnings in a range of $15.25 to $16.25 per share on a revenue decline in the mid-single digits at constant currency.
The Street is looking for earnings of $15.2 per share on a revenue decline of 5.16 percent to $9.18 billion for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Nachrichten zu Biogen Inc
|
13.05.25 |
Optimismus in New York: NASDAQ 100 zum Handelsstart mit positivem Vorzeichen (finanzen.ch) | |
|
12.05.25 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätten Anleger an einem Biogen-Investment von vor 5 Jahren verloren (finanzen.ch) | |
|
05.05.25 |
NASDAQ Composite Index-Papier Biogen-Aktie: So viel Verlust hätte ein Investment in Biogen von vor 3 Jahren bedeutet (finanzen.ch) | |
|
30.04.25 |
Ausblick: Biogen informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
|
28.04.25 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätten Anleger an einem Biogen-Investment von vor einem Jahr verloren (finanzen.ch) | |
|
22.04.25 |
NASDAQ-Handel: NASDAQ 100 schliesst im Plus (finanzen.ch) | |
|
22.04.25 |
NASDAQ-Handel: NASDAQ 100 freundlich (finanzen.ch) | |
|
22.04.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 legt zu (finanzen.ch) |